| Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap |
NCT00003962: Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
|
|
| Completed | 1 | | US | aldesleukin | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI) | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | 06/00 | 06/00 | | |
NCT00002746: Interleukin-2 in Treating Patients With Myelodysplastic Syndrome |
|
|
| Completed | 1 | 24 | US | aldesleukin | University of Washington | Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | 04/04 | 04/04 | | |
NCT00329368: Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer |
|
|
| Completed | 1 | 13 | US | EC90 (KLH-FITC), Keyhole limpet hemocyanin fluorescein, GPI-0100, Saponin-based adjuvant, EC17 (Folate-FITC), folate-fluorescein conjugate, folate-hapten conjugate, Interleukin-2, IL-2, Proleukin, Interferon-alpha, IFN-alpha, Intron-A | Endocyte | Cancer | 12/07 | 06/08 | | |
NCT00107354: Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant |
|
|
| Completed | 1 | | US | aldesleukin, therapeutic allogeneic lymphocytes, therapeutic autologous lymphocytes, cytarabine, etoposide, mitoxantrone hydrochloride, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation | Fred Hutchinson Cancer Center | Leukemia, Myelodysplastic Syndromes | 08/09 | | | |
NCT00003243: Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer |
|
|
| Completed | 1 | | US | aldesleukin, filgrastim, therapeutic allogeneic lymphocytes, cyclophosphamide, etoposide, pegylated liposomal doxorubicin hydrochloride | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI) | Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases | | | | |
NCT00301730: Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung |
|
|
| Completed | 1 | 1 | US | aldesleukin, therapeutic tumor infiltrating lymphocytes, trastuzumab, paclitaxel, conventional surgery | National Cancer Institute (NCI) | Breast Cancer, Metastatic Cancer | | | | |
